Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2015

01-12-2015 | Short Research Report

Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia

Authors: Silvana Anna Maria Urru, Luca Pasina, Paola Minghetti, Corrado Giua

Published in: International Journal of Clinical Pharmacy | Issue 6/2015

Login to get access

Abstract

Background The appropriate management of chronic insomnia is crucial and prescribing of hypnotic drugs is common. Regular and prolonged use of hypnotics should be avoided because of the risk of tolerance to effects, dependence and an increased risk of adverse events. In 2012, updated Beers criteria for potentially inappropriate medication in older adults suggested to avoid all benzodiazepines in older adults to treat insomnia. In addition, successful discontinuation may result in improvements on cognitive and psychomotor function, particularly in older people. Objective To investigate the appropriateness of benzodiazepines prescription for insomnia and explore the role that community pharmacists can have in identifying signals of potential inappropriate drug prescriptions. Setting Community pharmacies in Italy. Method This is an observational study conducted in 8 community pharmacies. Each pharmacist was asked to interview a sample of patients with the prescriptions of at least one benzodiazepine and to complete a minimum data set collecting information about socio-demographic characteristics, drug indication, duration of drug prescription, number of hypnotic-drugs, previous attempt to drug-discontinuation, preference of patients about benzodiazepine withdrawal and modality of drug tapering. Main outcome measure Indications, treatment duration, dosage and drug discontinuation attempts and modalities. Results A total of 181 participants were interviewed. About half of respondents (n = 81) reported to be treated for insomnia and 62 % were elderly (mean age 68, range 27–93). Fifty-two patients (64 %) were on long term treatment (>3 years) while for thirteen patients (16 %) duration of treatment was comprised between 1 and 3 years. Thirty-three patients were in favour of benzodiazepine-discontinuation but in all cases discontinuation was unsuccessful. Conclusion Use of community pharmacy survey data allowed us to obtain information about incorrect management of insomnia and inappropriate benzodiazepines prescriptions. Stricter adherence to evidence-based guidelines is essential for a rational use of hypnotic and sedatives.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Institutes of Health State of the Science. Conference statement on Manifestations and Management of Chronic Insomnia in Adults. Sleep. 2005;28:1049–57. National Institutes of Health State of the Science. Conference statement on Manifestations and Management of Chronic Insomnia in Adults. Sleep. 2005;28:1049–57.
3.
go back to reference Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedCentralPubMed Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487–504.PubMedCentralPubMed
4.
go back to reference Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272(4):292–6.CrossRefPubMed Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272(4):292–6.CrossRefPubMed
5.
go back to reference American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;6(4):616–31. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;6(4):616–31.
6.
go back to reference Marcum ZA, Hanlon JT. Commentary on the new American Geriatric Society Beers criteria for potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2012;10(2):151–9.PubMedCentralCrossRefPubMed Marcum ZA, Hanlon JT. Commentary on the new American Geriatric Society Beers criteria for potentially inappropriate medication use in older adults. Am J Geriatr Pharmacother. 2012;10(2):151–9.PubMedCentralCrossRefPubMed
7.
go back to reference Pasina L, Urru SAM, Giua C, Minghetti P. Role of community pharmacies for the detection of potentially inappropriate xanthine oxidase inhibitor prescriptions. Drugs: Real World Outcomes. 2015;2:81–6. Pasina L, Urru SAM, Giua C, Minghetti P. Role of community pharmacies for the detection of potentially inappropriate xanthine oxidase inhibitor prescriptions. Drugs: Real World Outcomes. 2015;2:81–6.
8.
go back to reference Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169.PubMedCentralCrossRefPubMed Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169.PubMedCentralCrossRefPubMed
9.
go back to reference British National Formulary. London: BMJ Group, Pharmaceutical Press, and RCPCH Publications; 2009. ISBN: 978-0-85369-848-7. British National Formulary. London: BMJ Group, Pharmaceutical Press, and RCPCH Publications; 2009. ISBN: 978-0-85369-848-7.
10.
go back to reference Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD Young R. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction. 2009;104(1):13–24.CrossRefPubMed Parr JM, Kavanagh DJ, Cahill L, Mitchell G, McD Young R. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction. 2009;104(1):13–24.CrossRefPubMed
11.
go back to reference Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323:1340–3.PubMedCentralCrossRefPubMed Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323:1340–3.PubMedCentralCrossRefPubMed
12.
go back to reference Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.CrossRefPubMed Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.CrossRefPubMed
Metadata
Title
Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia
Authors
Silvana Anna Maria Urru
Luca Pasina
Paola Minghetti
Corrado Giua
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2015
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0166-4

Other articles of this Issue 6/2015

International Journal of Clinical Pharmacy 6/2015 Go to the issue